Affiliation:
1. N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation
2. The State Education Institution of Higher Professional Training The First Sechenov Moscow State Medical University under Ministry of Health of the Russian Federation
Abstract
Quantitative assessment of estrogen receptors alpha (ERα) expression was carried out in 115 samples of non-small cell lung cancer (NSCLC) by an immuno uorescent assay and ow cytometry. It has been shown that high level of ERα ≥20% predicts higher aggressiveness of NSCLC than at low level <20%: median survival at 78 mos of follow-up is increased by 1.5 times; the risk of death is reduced by almost 2.0 times (p = 0.04). Time to death was increased by an average of 18 mos in about 20% of patients with low ERα expression. The results validate informative value of immuno uorescence analysis and owcytometry for quantifying the ERα expression and substantiate the prospects of antiestrogen therapy as a new option for NSCLC treatment, in particular, by analogy with breast cancer - in a long-term adjuvant therapy in ERα+ NSCLC patients.
Funder
Ministry of Science and Higher Education of the Russian Federation
Reference35 articles.
1. Slatore C.G., Chien J.W., Au D.H., Satia J.A., White E. // J. Clin. Oncol. 2010. Vol. 28. P. 1540 (DOI: 10.1200/JCO.2009.25.9739).
2. Chlebowski R.T., Wakelee H., Pettinger M., Rohan T., Liu J., Simon M., Tindle H., Messina C., Johnson K., Schwartz A., Gass M., Wactawski-Wende J. // Clin. Lung. Cancer. 2016. Vol. 17. N 1. P. 10.e1 (DOI: 10.1016/j.cllc.2015.09.004).
3. Ganti A.K., Sahmoun A.E., Panwalkar A.W., Tendulkar K.K., Potti A // J. Clin. Oncol. 2006. Vol.. 24. N 1. P. 59 (DOI:10.1200/JCO.2005.02.9827).
4. Rodriguez-Lara V., Hernandez-Martinez J.M., Arrieta O. // J. Thorac. Dis. 2018. Vol. 10. N 1 (DOI: 10.21037/jtd.2017.12.61).
5. Rodriguez-Lara V., Ignacio G.S., Cerbón Cervantes M.A. // Endocr Res. 2017. Vol. 42. N 3. P. 219 (DOI: 10.1080/07435800.2017.1292526).